Significant Ownership of Aberdeen Group plc

Signature - Title
F.Osei - Frederic Osei/Major Shareholding Reporting Analyst
Location
Edinburgh, United Kingdom
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Aberdeen Group plc.

Notify me when Aberdeen Group plc files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Aberdeen Group plc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
QNRX Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing Thirty-five (35) Ordinary Shares, no par value per share 8.9% $1,082,250 75,000 Aberdeen Group plc 31 Dec 2025
DTIL PRECISION BIOSCIENCES INC Common Stock, par value $0.000005 per share 8.9% $8,896,588 2,138,603 Aberdeen Group plc 31 Dec 2025
CDXS CODEXIS, INC. Common Stock, par value $0.0001 per share 8.8% $12,985,392 +$6,315,331 7,966,498 +95% Aberdeen Group plc 31 Dec 2025
CRBP Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share 7.5% $10,759,045 1,321,750 Aberdeen Group plc 31 Dec 2025
NSPR InspireMD, Inc. Common Stock, $0.0001 par value per share 7.5% $5,648,588 +$1,232,200 3,173,364 +28% Aberdeen Group plc 31 Dec 2025
IMUX IMMUNIC, INC. Common Stock, par value $0.0001 per share 6.8% $4,399,791 8,243,941 0% Aberdeen Group plc 31 Dec 2025
TECX Tectonic Therapeutic, Inc. Common Stock, $0.0001 par value per share 6.1% $23,818,449 1,141,824 Aberdeen Group plc 31 Dec 2025
SERA SERA PROGNOSTICS, INC. Class A Common Stock $0.0001 par value per share 6.1% $6,325,722 2,227,367 Aberdeen Group plc 30 Jun 2025
QURE uniQure N.V. Ordinary Shares, par value(euro)0.05 per share 5.9% $88,029,855 +$17,681,805 3,678,640 +25% Aberdeen Group plc 31 Dec 2025

Schedules 13D/G Reported by Aberdeen Group plc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.